Douglas Forsyth, Director at Inhibrx Biosciences, bought INBX on Sep 8, 2026

Data as of Oct 16

▲ BUY$287K2,500 shares at $114.65Douglas Forsyth DirectorINBX Inhibrx Biosciences, Inc.

Watch INBX

Traded: Sep 8, 2026
Disclosed: Sep 8, 2026
Filed: The same day

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

INBXSimilar stocks (XLV — its sector index fund), rebased to INBX's price on the disclosure day

INBX since disclosure

−21.4%

Similar stocks (XLV) since disclosure

+5.7%

XLV — its sector index fund

Change in closing price from Sep 8, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

See every trade on INBX →